(Q40108900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6197869%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

review article

1 reference

title

Treatment of acute leukemia--advances in chemotherapy, immunotherapy, and bone marrow transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6197869%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Treatment of Acute Leukemia–Advances in Chemotherapy, Immunotherapy, and Bone Marrow Transplantation (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

1 reference

G. Gahrton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6197869

26 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6197869

26 August 2023

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6197869%20AND%20SRC:MED&resulttype=core&format=json

Advances in Cancer Research

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6197869%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6197869%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

255-329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6197869%20AND%20SRC:MED&resulttype=core&format=json

Letter: Interferon in acute leukaemia in children

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Current concepts in immunology: Cell-surface markers in lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Cytogenetic Studies in Acute Leukaemias. Prognostic Implications of Chromosome Imbalances

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Remission maintenance of adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Podophyllotoxin derivative VP 16-213

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Antibodies as Carriers for Oncostatic Materials

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Childhood acute lymphocytic leukemia. Study VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Allogeneic marrow transplantation for acute leukemia in relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Immunogenicity of L 1210 Murine Leukaemia Cells after Treatment with Neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetyl vinblastine amide (vindesine) sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

The effect of transfusions and antibiotics upon the duration of life in children with lymphogenous leucemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Bone-Marrow Ablation and Allogeneic Marrow Transplantation in Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Terminal deoxynucleotidyl transferase expression in acute non-lymphoid leukaemia: an analysis by immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Acute lymphoblastic leukaemia in adults: Clinicopathological correlations with the French-American-British (FAB) co-operative group classification

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Antidote against the urotoxic effects of the oxazaphorine derivatives cyclophosphamide, ifosfamide and trofosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Protective environment for marrow transplant recipients: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

1 reference

7 January 2021

Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

The 24 fluorescence patterns of the human metaphase chromosomes - distinguishing characters and variability

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Increased survival in childhood acute nonlymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6-thioguanine, cyclophosphamide, and oncovin (PATCO) combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Acute lymphoblastic leukaemia in children: Classification and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Treatment of acute leukemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Marrow transplantation from donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using fractionated total body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Management of adult acute myelogenous leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Autologous bone marrow transplantation in patients with adult acute leukemia in relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

A randomized study of intermittent chemotherapy with or without BCG inoculation in maintenance therapy of childhood ALL

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Long-term results of reinforcement therapy in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Clinical trials with daunorubincin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Clonal origin of chronic myelocytic leukemia in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Acute myelogenous leukemia: Morphologic classification and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

The effect of chemotherapy on acute leukemia in the human

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Therapy of acute myelogeneous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Induction of remission with l-asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Chromosomal satellites as markers in human bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

High remission-induction rate in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Intensive chemotherapy for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Factors influencing survival in pediatric acute leukemia.The SWCCSG experience, 1958–1970

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Early deaths in newly diagnosed cases of pediatric acute leukemia.A southwest oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

A Reappraisal of the Results of Stopping Therapy in Childhood Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Atherosclerosis: The low-density lipoprotein receptor hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Elimination of T-lymphocytes from human bone marrow with monoclonal T-antibodies and cytolytic complement

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Colony-forming and colony-stimulating cells in relation to prognosis in leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Chronic graft versus host disease: a syndrome of disordered immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Prognostic importance of immunologic markers in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

The Prognostic Significance of in Vitro Bone Marrow Growth Pattern in Acute Non‐Lymphocytic Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Acute lymphoblastic leukemia in Swedish children 1973-1978

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: Results of CALGB protocol 7113

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Prognostic Value of Colony-stimulating and Colony-forming cells in Peripheral Blood in Acute Non-lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

In vitro colony studies in 87 patients with acute nonlymphoblastic leukemia. Prognostic value of colony-stimulating activity and colony-forming cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Relations between chromosomal findings and prognosis in acute nonlymphoblastic leukemia (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Cytosine arabinoside. Results of a cooperative study in acute childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Plasma levels and biotransformation of infused daunorubicin and daunorubicin-DNA complex in rabbits: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

VP 16-213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Virus interference. I. The interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Treatment of Acute Myeloblastic Leukaemia with RP 22050

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

A survey of the anthracycline derivatives in hematology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

The role of vincristine in the treatment of childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Potential of liposomes as drug-carriers in cancer chemotherapy: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Activity of indicine N-oxide in refractory acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

A comparative clinical trial of 5-azacytidine and guanazole in previously treated adults with acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Clinical and pharmacologic studies with adriamycin-DNA complex in children with malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Combination chemotherapy for acute lymphoblastic leukaemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Chemotherapy and immunotherapy for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Active immunotherapy for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

The current status of the treatment of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

IMMUNOLOGY OF EXPERIMENTAL TUMORS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Treatment of acute myelogenous leukemia: influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Reducing the cardiotoxicity of anthracyclines by complex-binding to DNA: report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Radiobiological Considerations in the Use of Total-Body Irradiation for Bone-Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Treatment of acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Bone-marrow transplantation in leukaemia remission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

The central nervous system in childhood leukemia.II. Subacute leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

A randomized study of the prevention of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Experience with a cooperative bone marrow transplantation program in Stockholm

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

POMP combination chemotherapy of adult acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Antibodies as carriers of anticancer agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Effect of schedule on activity and toxicity of 5-azacytidine in acute leukemia: A southwest oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Clinical importance of lymphoblasts with T markers in childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Hyperfractionated total body irradiation for bone marrow transplantation: I. Early results in leukemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Adriamycin in combination chemotherapy of adult acute lymphoblastic leukemia: A southwest oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Initial features and prognosis in 363 children with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

VP 16-213 in acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Combination chemotherapy of adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Adenosine deaminase activity in leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

A study of the natural history of acute leukemia with special reference to the duration of the disease and the occurrence of remissions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Distribution of 250 cases of acute myeloid leukaemia (AML) according to the FAB classification and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Chromosome 21 and the cell growth inhibitory effect of human interferon preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Bone-marrow transplantation for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Irradiation and marrow infusion in leukemia. Observations in five patients with acute leukemia treated by whole-body exposures of 1,400 to 2,000 roentgens and infusions of marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

The natural history of untreated acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Daunorubicin-DNA and doxorubicin-DNA a review of experimental and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Rule governing Cell Division in Anabaena

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Experimental leukemia chemotherapy with a "lysosomotropic" adriamycin-DNA complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Radiation pneumonitis following large single dose irradiation: a re-evaluation based on absolute dose to lung

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Long chemotherapy-free remissions after single-cycle timed-sequential chemotherapy for acute myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Comparison of methotrexate with 6-mercaptopurine–prednisone in treatment of acute leukemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Prolonged infusion of arabinosyl cytosine in childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

OBSERVATIONS ON THE REPEATED ADMINISTRATION OF VIRUSES TO A PATIENT WITH ACUTE LEUKEMIA. A PRELIMINARY REPORT.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Acute granulocytic leukemia: treatment of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Treatment of acute myelogenous leukemia in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Fresh blood transfusion in leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Leukaemia Classification: a Study of the Accuracy of Diagnosis in 456 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Active immunotherapy for the treatment of acute myelogenous leukaemia: report of two controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

Predinsome therapy of acute childhood leukemia: Prognosis and duration of response in 330 treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

A phase II study of aclacinomycin A in acute leukemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

All patients with acute nonlymphocytic leukemia may have a chromosomal defect

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960682-X

7 January 2021

8

2

15

Andersson

1979

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

12

40

3304

Arlin

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

25

43

1389

Bast

1983

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

28

31

2130

Bekesi

1971

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

38

63

977

Bleyer

1979

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

40

41

4857

Bloomfield

1981

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

59

37

2138

Burke

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

Texas Reports on Biology and Medicine

26 August 2023

62

35

138

Cantell

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

96

3

744

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

Progress and Perspectives in the Chemotherapy of Acute Leukemia

26 August 2023

109

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

111

29

1325

Frei

1969

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

119

2

73

Gahrton

1979

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

Predictive Value of in vitro Colony and Cluster Formation in Acute Nonlymphocytic Leukemia

26 August 2023

129

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

Journal of Medicinal Chemistry

26 August 2023

141

12

199

Grever

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

142

37

2998

Grieder

1977

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

Successful Treatment with Prednisone of Graft-Versus-Host Disease in an Allogeneic Bone-Marrow Transplant Recipient

26 August 2023

143

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

161

3

243

Hulhoven

1979

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

166

33

3278

Jacquillat

1973

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

184

63

4

Koller

1979

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

186

21

1015

Krakoff

1961

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

197

38

4251

Lippman

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

200

65

995

Look

1981

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

212

63

805

Mathé

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

215

66

1455

Mayer

1982

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

229

43

3047

Nadler

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

245

Paul

1982

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

256

4

3343

Poplack

1981

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

257

65

53

Poster

1981

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

280

author name string

Rivera

publication date

1982

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

283

62

493

Rodriguez

1978

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

290

64

869

Ryan

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

300

63

501

Scheef

1979

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

357

40

1516

Von Hoff

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

361

36

1441

Wang

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

365

33

921

Weil

1973

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

373

32

2023

Wiemik

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

374

60

41

Wiernik

1976

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60682-X

26 August 2023

Identifiers

0 references

1 reference